Scope Infection Lawsuit Patients across the United States have filed medical scope infection lawsuits after contaminated endoscopes and duodenoscopes allegedly transmitted dangerous bacterial infections during procedures such as ERCP, colonoscopy, and other endoscopic treatments.
Spinal Cord Stimulator Lawsuit Spinal cord stimulator lawsuits allege that implanted pain devices malfunctioned, migrated, or caused nerve damage, often forcing patients to undergo revision or removal surgery.
Chlorpyrifos Parkinsonโs Disease Lawsuit Chlorpyrifos lawsuits are being investigated for individuals diagnosed with Parkinsonโs disease after direct, residential, occupational or Gulf War pesticide exposure.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Breast Mesh Lawsuit Lawyers are investigating breast mesh lawsuits for women who suffered infections, pain, or implant failure from internal bra implants used in breast reconstruction surgery.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Merrill Lynch Sale of GM Notes Results in $1.9M Fine Over Unfair Pricing December 17, 2014 Irvin Jackson Add Your CommentsA financial industry oversight group has fined Merrill Lynch $1.9 million for purchasingย General Motors notes at unfair prices, also ordering the company to pay $540,000 in restitution to customers.ย The Financial Industry Regulatory Authority (FINRA) determined that Merrill Lynch bought Motors Liquidation Company Senior Notes from retail customers at discounts ranging from 5.3% to 61.5% below market price, then sold them to other brokers and dealers at market prices. Most had markdowns of more than 10% when the company purchased them.Theย judgment and fines against Merrill Lynch were announced by FINRA in a December 16 press release, indicating that the GM notes, sold by the auto maker before its bankruptcy, were purchased from customers at unfair prices. FINRA found 716 instances where customers were not paid enough for the GM notes.Do You Know about…Spinal Cord Stimulator lawsuitsSpinal cord stimulator lawsuits are being investigated for individuals who suffered unnecessary shocks, burns or other problems, often resulting in the need for additional surgery to remove the SCS.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONDo You Know AboutโฆSpinal Cord Stimulator lawsuitsSpinal cord stimulator lawsuits are being investigated for individuals who suffered unnecessary shocks, burns or other problems, often resulting in the need for additional surgery to remove the SCS.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONThe restitution, which includes interest, is to be paid to the customers who sold Merrill Lynch’s Global Banking & Markets Credit Trading Desk the notes at unfair prices.In addition to the unfair pricing charge, FINRA also determined that the problems occurred because the company failed to adequately supervise the credit desk, and did not properly review its transactions. FINRA has ordered the company to create three reports over the next 18 months detailing its system of supervising the pricing of retail customer transactions made by its credit desk.“We expect firms to adhere to their fair pricing obligations to customers when transacting in lower-priced or distressed securities,” said Thomas Gira, FINRA Executive Vice President and Head of Market Regulation. “Even after factoring in the nature of the market for these types of instruments, the markdowns charged were simply unacceptable, as was Merrill Lynch’s failure to conduct post-trade fair pricing or best execution reviews for customer transactions executed on the Credit Desk.”Merrill Lynch neither admitted to nor denied the charges, FINRA officials said. The company has said that it has already taken disciplinary action and is addressing the problems that led to the marked down purchases. Written by: Irvin JacksonSenior Legal Journalist & Contributing EditorIrvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Financial Fraud, FINRA, General Motors (GM), Merrill LynchMore Lawsuit Stories J&J Agrees to $5.5B Talcum Powder Settlement Payout to Resolve Ovarian Cancer Lawsuits July 29, 2026 CTCL Lawsuit Alleges Diagnosis Came After Less Than a Year of Dupixent Use July 29, 2026 Instant Pot Duo Nova Lawsuit Alleges Defective Pressure Cooker Caused Serious Burns July 29, 2026 0 Comments URLThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes NoPost Comment I authorize the above comments be posted on this pageWeekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings.Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermΔ MORE TOP STORIES J&J Agrees to $5.5B Talcum Powder Settlement Payout to Resolve Ovarian Cancer Lawsuits (Posted: yesterday)A $5.5 billion settlement deal could resolve nearly 80,000 talcum powder cancer lawsuits that claim Johnson & Johnson products were contaminated with asbestos.MORE ABOUT: TALCUM POWDER CANCER LAWSUITSAdditional Talks To Settle Talcum Powder Cancer Lawsuits Set for April 13 (03/20/2026)Ovarian Cancer Talcum Powder Lawsuit Results in $250K Verdict Against J&J (02/16/2026)Evidence That Baby Powder Causes Ovarian Cancer Should Be Admissible At Trial: Report (01/22/2026) Chlorpyrifos Exposure Lawsuit Claims Pesticide Caused Farmer’s Parkinson’s Disease Diagnosis (Posted: 2 days ago)A chlorpyrifos lawsuit claims years of exposure through residence and work left a California man with a Parkinson’s disease diagnosis.MORE ABOUT: CHLORPYRIFOS PARKINSONโS DISEASE LAWSUITChlorpyrifos Parkinsonโs Disease Lawsuit Claims Years of Insecticide Exposure Caused Neurological Side Effects (07/22/2026)Chlorpyrifos (CPF) Exposure Linked to Abnormal Brain Development in Children: Study (08/27/2025)Court Ruling Allows EPA to Proceed with Chlorpyrifos Ban (10/23/2023) Spinal Cord Stimulator Reprogramming Caused Electric Shocks, Worsening Pain: Lawsuit (Posted: 3 days ago)Abbott faces a Proclaim spinal cord stimulator lawsuit by a man who says the device not only failed, but that he was repeatedly electrocuted when sales representatives without medical licenses tried to reprogram it.MORE ABOUT: SPINAL CORD STIMULATOR LAWSUITAbbott Faces Spine Stimulator Lawsuit Brought Jointly by 17 Injured Patients (07/23/2026)Boston Scientific Spinal Cord Stimulator Lawyers to Meet With MDL Judge for Initial Conference Aug. 5 (07/16/2026)Spinal Cord Stimulator Lawsuit Claims Boston Scientific Sales Reps Made Unauthorized Device Adjustments (07/13/2026)
J&J Agrees to $5.5B Talcum Powder Settlement Payout to Resolve Ovarian Cancer Lawsuits (Posted: yesterday)A $5.5 billion settlement deal could resolve nearly 80,000 talcum powder cancer lawsuits that claim Johnson & Johnson products were contaminated with asbestos.MORE ABOUT: TALCUM POWDER CANCER LAWSUITSAdditional Talks To Settle Talcum Powder Cancer Lawsuits Set for April 13 (03/20/2026)Ovarian Cancer Talcum Powder Lawsuit Results in $250K Verdict Against J&J (02/16/2026)Evidence That Baby Powder Causes Ovarian Cancer Should Be Admissible At Trial: Report (01/22/2026)
Chlorpyrifos Exposure Lawsuit Claims Pesticide Caused Farmer’s Parkinson’s Disease Diagnosis (Posted: 2 days ago)A chlorpyrifos lawsuit claims years of exposure through residence and work left a California man with a Parkinson’s disease diagnosis.MORE ABOUT: CHLORPYRIFOS PARKINSONโS DISEASE LAWSUITChlorpyrifos Parkinsonโs Disease Lawsuit Claims Years of Insecticide Exposure Caused Neurological Side Effects (07/22/2026)Chlorpyrifos (CPF) Exposure Linked to Abnormal Brain Development in Children: Study (08/27/2025)Court Ruling Allows EPA to Proceed with Chlorpyrifos Ban (10/23/2023)
Spinal Cord Stimulator Reprogramming Caused Electric Shocks, Worsening Pain: Lawsuit (Posted: 3 days ago)Abbott faces a Proclaim spinal cord stimulator lawsuit by a man who says the device not only failed, but that he was repeatedly electrocuted when sales representatives without medical licenses tried to reprogram it.MORE ABOUT: SPINAL CORD STIMULATOR LAWSUITAbbott Faces Spine Stimulator Lawsuit Brought Jointly by 17 Injured Patients (07/23/2026)Boston Scientific Spinal Cord Stimulator Lawyers to Meet With MDL Judge for Initial Conference Aug. 5 (07/16/2026)Spinal Cord Stimulator Lawsuit Claims Boston Scientific Sales Reps Made Unauthorized Device Adjustments (07/13/2026)